These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Allosteric enhancers, allosteric agonists and ago-allosteric modulators: where do they bind and how do they act? Schwartz TW; Holst B Trends Pharmacol Sci; 2007 Aug; 28(8):366-73. PubMed ID: 17629958 [TBL] [Abstract][Full Text] [Related]
12. The NMDA receptor complex: a long and winding road to therapeutics. Wood PL IDrugs; 2005 Mar; 8(3):229-35. PubMed ID: 15772895 [TBL] [Abstract][Full Text] [Related]
13. New concepts in drug discovery: collateral efficacy and permissive antagonism. Kenakin T Nat Rev Drug Discov; 2005 Nov; 4(11):919-27. PubMed ID: 16264435 [TBL] [Abstract][Full Text] [Related]
15. Allosteric modulation of G protein-coupled receptors: perspectives and recent developments. Soudijn W; Van Wijngaarden I; IJzerman AP Drug Discov Today; 2004 Sep; 9(17):752-8. PubMed ID: 15450241 [TBL] [Abstract][Full Text] [Related]
16. Allosterism and cannabinoid CB(1) receptors: the shape of things to come. Ross RA Trends Pharmacol Sci; 2007 Nov; 28(11):567-72. PubMed ID: 18029031 [TBL] [Abstract][Full Text] [Related]
17. Determining the potency and molecular mechanism of action of insurmountable antagonists. Kenakin T; Jenkinson S; Watson C J Pharmacol Exp Ther; 2006 Nov; 319(2):710-23. PubMed ID: 16857731 [TBL] [Abstract][Full Text] [Related]
18. Structure-function studies of allosteric agonism at M2 muscarinic acetylcholine receptors. May LT; Avlani VA; Langmead CJ; Herdon HJ; Wood MD; Sexton PM; Christopoulos A Mol Pharmacol; 2007 Aug; 72(2):463-76. PubMed ID: 17525129 [TBL] [Abstract][Full Text] [Related]